News

Low risk prostate cancer: real-world data reveals high rates of switching from surveillance to treatment

Over half of men initially managed with active surveillance (AS) for ‘low risk’ prostate cancer switch within four years to definitive treatments (e.g., surgery or radiation therapy). The Canadian study, published in…

News

Blood pressure drugs improve survival in colorectal cancer

Common Blood pressure drugs may improve survival in colorectal cancer (CRC). The study, published in Cancer Medicine, (August issue), showed use of Angiotensin Converting Enzyme (ACE) inhibitors, beta blockers and thiazide diuretics…

News

Cancer community fights back against Covid-19 related delays

The European Cancer Organisation is making materials available to download in 30 different languages to help advocates across Europe lobby national governments to tackle the Covid-19 threat to cancer services in their…

News

Addressing social needs may help cancer outcomes

Identifying social needs of cancer patients and developing interventions to mitigate them could improve health outcomes. The survey-based study, published in Cancer (12 July), found unmet social needs in gynaecological cancers were…

News

Aspirin cuts risk of death from a wide range of cancers

Taking aspirin together with cancer treatment results in reductions in death from cancer and all-cause mortality, both by around one fifth. The meta-analysis, published in ecancermedicalscience, (online 2 July), demonstrates benefits for…

Articles

Lung cancer screening: time to act on the evidence

“It’s extraordinary that screening for the biggest cancer killer is not available in most of Europe," says Anne Marie Baird, President of Lung Cancer Europe (LuCE). “Lung cancer causes more deaths in…

News

Heart failure may be oncogenic, statins could reduce cancer risk

Two studies highlight the relationship between heart failure and cancer, showing people with heart failure are more likely to develop cancer, and that statins may reduce that risk. The first study, published…

News

ACE inhibitor protects against cardiotoxicity

In HER2 breast cancer, concurrent use of the ACE inhibitor lisinopril with trastuzumab-anthracyclines benefits left ventricular ejection fraction (LVEF). The study, abstract 509, presented in a poster session at the ASCO meeting,…

News

Advance Care Planning increases hope

Hope for cancer patients may be increased by engaging in advanced care planning (ACP). The study, abstract 12029, presented in a poster session at ASCO, which took place online June 4-8, found…

News

Wake-up call to offer equal access to life-prolonging treatments in metastatic prostate cancer

Less than one third of men with metastatic castration-sensitive prostate cancer (mCSPC) received established treatment intensification by 2018 that had been demonstrated to extend survival. The US study evaluating real-world utilization of…